about
Plasmin cleaves the juxtamembrane domain and releases truncated species of the urokinase receptor (CD87) from human bronchial epithelial cells.Common coding variant in SERPINA1 increases the risk for large artery stroke.Kallikrein-related peptidase 4: a new activator of the aberrantly expressed protease-activated receptor 1 in colon cancer cellsSequestration of latent TGF-β binding protein 1 into CADASIL-related Notch3-ECD depositsCerebral small vessel disease-related protease HtrA1 processes latent TGF-β binding protein 1 and facilitates TGF-β signalingDisruption of the endothelial barrier by proteases from the bacterial pathogen Pseudomonas aeruginosa: implication of matrilysis and receptor cleavageHeterozygous HTRA1 mutations are associated with autosomal dominant cerebral small vessel disease.Activation of human pro-urokinase by unrelated proteases secreted by Pseudomonas aeruginosa.Interdependence of kallikrein-related peptidases in proteolytic networks.Reply to Liu et al.: Loss of TGF-β signaling in CARASIL pathogenesis.Efficient factor VIII affinity purification using a small synthetic ligand.Interplay of human tissue kallikrein 4 (hK4) with the plasminogen activation system: hK4 regulates the structure and functions of the urokinase-type plasminogen activator receptor (uPAR).Development of a small molecule peptidomimetic affinity ligand for efficient purification of the large protein factor VIII.The thermolysin-like metalloproteinase and virulence factor LasB from pathogenic Pseudomonas aeruginosa induces anoikis of human vascular cells.The human airway trypsin-like protease modulates the urokinase receptor (uPAR, CD87) structure and functions.In vitro and in vivo evidence for the role of elastase shedding of CD163 in human atherothrombosisA novel HTRA1 exon 2 mutation causes loss of protease activity in a Pakistani CARASIL patient
P50
Q31110978-C12228DF-045E-48C2-A295-EA8D68FDA66EQ33556760-1CF4AFA9-3A9E-4292-88E1-6AA4087D38A4Q33703798-8DD65033-BC0D-45E3-94C4-C370E0C7CB02Q34571315-5D7E4711-8D29-4814-AF07-AC813354FE09Q34581220-B1B9135F-D752-4058-8E27-63669789D140Q34999718-324FB874-443B-4411-8B07-9E0222226D1FQ40847527-3F6DF26D-2A70-4AB5-AAB7-D3243B656F82Q43118896-BF6BDB2F-3B27-4D5D-A2AD-711F63A2A592Q43123723-C53CB6FD-AA1E-4ED6-A262-42AAFB19F851Q43228066-355DE614-40C7-4BC7-BD24-4AEA7F62C261Q45874455-B1DF1CAD-B50F-43C9-B760-83E490E063BDQ46959722-CC467B42-7A8B-4DF5-806A-557ED19A0A99Q47925890-644DB15B-9059-4C80-B76D-4DC7ECA22CB1Q52610170-BAEE0D5B-FB02-48B3-BD9B-78878003F8B0Q53576300-C27C951D-1FD8-446C-90DB-7A5DB1D4276DQ57243353-E59655E9-8861-4B7C-BB56-1764DF1F6EC3Q62980703-4A306E5C-E7C4-4DA7-A65B-4EC556D688CC
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nathalie Beaufort
@ast
Nathalie Beaufort
@en
Nathalie Beaufort
@es
Nathalie Beaufort
@nl
Nathalie Beaufort
@sl
type
label
Nathalie Beaufort
@ast
Nathalie Beaufort
@en
Nathalie Beaufort
@es
Nathalie Beaufort
@nl
Nathalie Beaufort
@sl
prefLabel
Nathalie Beaufort
@ast
Nathalie Beaufort
@en
Nathalie Beaufort
@es
Nathalie Beaufort
@nl
Nathalie Beaufort
@sl
P106
P21
P31
P496
0000-0002-7088-4206